Odyssey Health, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ODYY research report →
Companywww.odysseyhealthinc.com
Odyssey Health, Inc. , a medical company, focuses on developing medical products. It develops CardioMap, a heart monitoring and screening device; Save A Life choking rescue devices; and PRV-001 and PRV-002 neurosteroid drug compounds to treat concussions and rare brain disorders.
- CEO
- Joseph Michael Redmond
- IPO
- 2021
- Employees
- 4
- HQ
- Las Vegas, NV, US
Price Chart
Valuation
- Market Cap
- $1.99M
- P/E
- -0.47
- P/S
- 0.00
- P/B
- -0.20
- EV/EBITDA
- -8.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 58.44%
- ROIC
- 9.24%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-1,742,691 · -92.40%
- EPS
- $-0.02 · -78.49%
- Op Income
- $-1,020,753
- FCF YoY
- 71.41%
Performance & Tape
- 52W High
- $0.13
- 52W Low
- $0.01
- 50D MA
- $0.06
- 200D MA
- $0.06
- Beta
- -1.36
- Avg Volume
- 108.98K
Get TickerSpark's AI analysis on ODYY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 28, 24 | FARRELL CHRISTINE | other | 500,000 |
| Jun 28, 24 | RICHARDSON RICKY | other | 300,000 |
| Jun 28, 24 | Casey Jerome H | other | 300,000 |
| Jun 28, 24 | REDMOND J MICHAEL | other | 500,000 |
| Jun 28, 24 | Gironda Gregory W | other | 250,000 |
| Jan 16, 24 | Gironda Gregory W | other | 37,500 |
| Jan 16, 24 | Emerson Erik C. | other | 37,500 |
| Jan 10, 24 | GANDOLFO JOHN P | other | 1,500,000 |
| Jan 10, 24 | GANDOLFO JOHN P | sell | 1,500,000 |
| Dec 29, 23 | Emerson Erik C. | other | 200,000 |
Our ODYY Coverage
We haven't published any research on ODYY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ODYY Report →